Logo

Iktos and SRI Collaborate to Accelerate Discovery and Development of Novel Anti-Viral Therapies

Share this

Iktos and SRI Collaborate to Accelerate Discovery and Development of Novel Anti-Viral Therapies

Shots:

  • The collaboration will combine Iktos’ generative modeling AI technology with SRI’s SynFini synthetic chemistry platform to develop optimized compound & to facilitate the identification of drug therapies treating multiple viruses- including influenza and COVID-19
  • Iktos’AI technology is based on deep generative models that speed up the drug discovery process by automatically designing virtual novel molecules having desirable characteristics of a novel drug therapies
  • SRI’s SynFini platform is designed to accelerate discovery and development by automating the design- RSO and production of target molecules. The collaboration demonstrates a new paradigm in rapid discovery against pharmaceutical targets

Click here ­to­ read full press release/ article | Ref: SRI | Image: Iktos


Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions